{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:14:45Z","timestamp":1788984885458,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jgar.2024.03.013","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T23:33:18Z","timestamp":1712791998000},"page":"208-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Emergence of HIV-1 drug resistance mutations among children and adolescents undergoing prolonged antiretroviral therapy in Guangxi"],"prefix":"10.1016","volume":"37","author":[{"given":"Xianwu","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningye","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haomin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2024.03.013_bib0001","unstructured":"UNAIDS, Global HIV & AIDS statistics - Global factsheet. 2020. https:\/\/aidsinfo.unaids.org\/. [cited 15-11-2023]."},{"key":"10.1016\/j.jgar.2024.03.013_bib0002","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/510489","article-title":"Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy","volume":"44","author":"Puthanakit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2024.03.013_bib0003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QAI.0b013e3181b9869f","article-title":"Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era","volume":"53","author":"Brady","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jgar.2024.03.013_bib0004","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1093\/jac\/dky348","article-title":"High prevalence of virological failure and HIV drug mutations in a first-line cohort of Malawian children","volume":"73","author":"Huibers","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.03.013_bib0005","unstructured":"WHO. HIV drug resistance report 2019. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-19.21."},{"key":"10.1016\/j.jgar.2024.03.013_bib0006","first-page":"537","article-title":"[Characteristics of newly reported HIV\/AIDS cases with non-marital or non-commercial heterosexual transmission in Guangxi Zhuang Autonomous Region, 2015\u20132018]","volume":"41","author":"Liu","year":"2020","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.jgar.2024.03.013_bib0007","first-page":"315","article-title":"[Epidemiological characteristics of HIV\/AIDS in Guangxi Zhuang Autonomous Region, 2010\u20132017]","volume":"40","author":"Ge","year":"2019","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.jgar.2024.03.013_bib0008","doi-asserted-by":"crossref","first-page":"21416","DOI":"10.7448\/IAS.20.1.21416","article-title":"Disclosure of sexual orientation to health professionals in China: results from an online cross-sectional study","volume":"20","author":"Tang","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jgar.2024.03.013_bib0009","unstructured":"State Council AIDS Working Committee office and UN Theme Group on HIV\/AIDS in China: a joint assessment of HIV\/AIDS prevention, treatment and care in China. 2004."},{"key":"10.1016\/j.jgar.2024.03.013_bib0010","unstructured":"World Bank. Allocating resources to control HIV\/AIDS in Guangxi Zhuang Autonomous Region: potential relevance for China. 2007."},{"key":"10.1016\/j.jgar.2024.03.013_bib0011","unstructured":"The People's Governemnt of Zhuang Guangxi Autonomous Region. Implementation plan of Guangxi AIDS Conquering Project (2010\u20132014). 2010."},{"key":"10.1016\/j.jgar.2024.03.013_bib0012","first-page":"5","article-title":"Progress towards the 90-90-90 targets for controlling HIV: China, 2018","volume":"1","author":"Zhao","year":"2019","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.jgar.2024.03.013_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.100238","article-title":"Trend of HIV-1 drug resistance in China: a systematic review and meta-analysis of data accumulated over 17 years (2001\u20132017)","volume":"18","author":"Zuo","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jgar.2024.03.013_bib0014","doi-asserted-by":"crossref","first-page":"e25455","DOI":"10.1002\/jia2.25455","article-title":"What do the universal test and treat trials tell us about the path to HIV epidemic control?","volume":"23","author":"Havlir","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"Suppl 3","key":"10.1016\/j.jgar.2024.03.013_bib0015","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1097\/QAD.0000000000002355","article-title":"Global, regional and country-level 90-90-90 estimates for 2018: assessing progress towards the 2020 target","volume":"33","author":"Marsh","year":"2019","journal-title":"AIDS"},{"issue":"Suppl 9","key":"10.1016\/j.jgar.2024.03.013_bib0016","doi-asserted-by":"crossref","first-page":"S838","DOI":"10.1093\/infdis\/jix407","article-title":"Impact of human immunodeficiency virus drug resistance on treatment of human immunodeficiency virus infection in children in low- and middle-income countries","volume":"216","author":"Siberry","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2024.03.013_bib0017","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/QAI.0000000000002308","article-title":"The HIV continuum of care for adolescents and young adults attending 13 urban US HIV care centers of the NICHD-ATN-CDC-HRSA SMILE Collaborative","volume":"84","author":"Kapogiannis","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jgar.2024.03.013_bib0018","doi-asserted-by":"crossref","first-page":"e72630","DOI":"10.1371\/journal.pone.0072630","article-title":"Prevalence and mutation patterns of HIV drug resistance from 2010 to 2011 among ART-failure individuals in the Yunnan Province","volume":"8","author":"Li","year":"2013","journal-title":"China. PLoS One"},{"key":"10.1016\/j.jgar.2024.03.013_bib0019","first-page":"950","article-title":"[Analysis of HIV-1 drug resistance among 1 922 individuals experiencing virological failure of first-line antiretroviral therapy in Henan province]","volume":"49","author":"Liu","year":"2015","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/j.jgar.2024.03.013_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/jiaa683","article-title":"Clinical impact of pretreatment human immunodeficiency virus drug resistance in people initiating nonnucleoside reverse transcriptase inhibitor-containing antiretroviral therapy: a systematic review and meta-analysis","volume":"224","author":"Bertagnolio","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2024.03.013_bib0021","doi-asserted-by":"crossref","first-page":"e20357","DOI":"10.1371\/journal.pone.0020357","article-title":"Emergence and persistence of minor drug-resistant HIV-1 variants in Ugandan women after nevirapine single-dose prophylaxis","volume":"6","author":"Hauser","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2024.03.013_bib0022","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-8603-4-5","article-title":"Dangerous medicines: unproven AIDS cures and counterfeit antiretroviral drugs","volume":"4","author":"Amon","year":"2008","journal-title":"Global Health"},{"key":"10.1016\/j.jgar.2024.03.013_bib0023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3851\/IMP1745","article-title":"Nevirapine versus atazanavir\/ritonavir, each combined with tenofovir disoproxil fumarate\/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN trial","volume":"16","author":"Soriano","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jgar.2024.03.013_bib0024","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/aid.2012.0283","article-title":"Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children","volume":"29","author":"Musiime","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jgar.2024.03.013_bib0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jac\/dkab430","article-title":"Drug resistance profiles and influencing factors among HIV-infected children and adolescents receiving long-term ART: a multicentre observational study in China","volume":"77","author":"Yan","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.03.013_bib0026","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/QAI.0b013e318229f2a2","article-title":"Drug resistance profiles among HIV-1-infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: an observational cohort study in rural China","volume":"58","author":"Zhao","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jgar.2024.03.013_bib0027","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/jac\/dky300","article-title":"Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa","volume":"73","author":"Fofana","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.03.013_bib0028","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1128\/AAC.00591-12","article-title":"Antiviral drug resistance and the need for development of new HIV-1 reverse transcriptase inhibitors","volume":"56","author":"Asahchop","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.03.013_bib0029","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1002\/jmv.26988","article-title":"HIV-1 subtypes and drug resistance in children during antiretroviral therapy in Brazil","volume":"93","author":"de Andrade Arrais","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jgar.2024.03.013_bib0030","first-page":"11","article-title":"HIV-1 disease progression and drug resistance mutations among children on first-line antiretroviral therapy in Ethiopia","author":"Getaneh","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jgar.2024.03.013_bib0031","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/jac\/dkac407","article-title":"Drug resistance in children and adolescents with HIV in Panama","volume":"78","author":"Ventosa-Cubillo","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.03.013_bib0032","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/aid.2015.0215","article-title":"HIV drug resistance among children initiating first-line antiretroviral treatment in Uganda","volume":"32","author":"Kityo","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jgar.2024.03.013_bib0033","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12879-021-05854-w","article-title":"HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in southwest China","volume":"21","author":"Pang","year":"2021","journal-title":"BMC Infect Dis"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524000651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524000651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T03:27:30Z","timestamp":1718681250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716524000651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":33,"alternative-id":["S2213716524000651"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2024.03.013","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of HIV-1 drug resistance mutations among children and adolescents undergoing prolonged antiretroviral therapy in Guangxi","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2024.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}